- Published
- 2021-10-09
- Venue
- New England Journal of Medicine, vol. 385, no. 16, pp. 1445-1447
- Cited by
- 296
- Open access
- No free copy found
- DOI
- 10.1056/nejmp2109826
- PubMed
- 34623789
Abstract
Doses and schedules of oncology drugs are sometimes inadequately characterized before registration trials. The “more is better” paradigm is still used for dose selection, despite the recognition that targeted therapies require alternative approaches to dose optimization.
Cite this paper
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
- APA 7
Shah, M., Rahman, A., Theoret, M. R., & Pazdur, R. (2021). The Drug-Dosing Conundrum in Oncology — When Less Is More. New England Journal of Medicine, 385(16), 1445–1447. https://doi.org/10.1056/nejmp2109826
- MLA 9
Shah, Mirat, et al. "The Drug-Dosing Conundrum in Oncology — When Less Is More." New England Journal of Medicine, vol. 385, no. 16, 2021, pp. 1445–1447, https://doi.org/10.1056/nejmp2109826.
- Chicago
Shah, Mirat, Atiqur Rahman, Marc Robert Theoret, and Richard Pazdur. "The Drug-Dosing Conundrum in Oncology — When Less Is More." New England Journal of Medicine 385, no. 16 (2021): 1445–1447. https://doi.org/10.1056/nejmp2109826.
- GOST
Shah M., Rahman A., Theoret M. R. [и др.] The Drug-Dosing Conundrum in Oncology — When Less Is More // New England Journal of Medicine. — 2021. — Vol. 385, № 16. — P. 1445–1447. — URL: https://doi.org/10.1056/nejmp2109826
- BibTeX
@article{shah2021drugdosing, title = {{The Drug-Dosing Conundrum in Oncology — When Less Is More}}, author = {Mirat Shah and Atiqur Rahman and Marc Robert Theoret and Richard Pazdur}, journal = {New England Journal of Medicine}, year = {2021}, volume = {385}, number = {16}, pages = {1445--1447}, doi = {10.1056/nejmp2109826}, url = {https://doi.org/10.1056/nejmp2109826} }- RIS
TY - JOUR AU - Shah, Mirat AU - Rahman, Atiqur AU - Theoret, Marc Robert AU - Pazdur, Richard TI - The Drug-Dosing Conundrum in Oncology — When Less Is More JO - New England Journal of Medicine VL - 385 IS - 16 SP - 1445 EP - 1447 PY - 2021 DA - 2021/10/09 DO - 10.1056/nejmp2109826 UR - https://doi.org/10.1056/nejmp2109826 ER -